Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03360006 |
| Title | A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Subjects With Advanced Prostate Cancer (CRPC) and Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AbbVie |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UC Irvine /ID# 160789 | Orange | California | 92868 | United States | Details | |
| University of California, Davis Comprehensive Cancer Center /ID# 202729 | Sacramento | California | 95817 | United States | Details | |
| Northwestern /ID# 171098 | Chicago | Illinois | 60611 | United States | Details | |
| University of Chicago DCAM /ID# 160702 | Chicago | Illinois | 60637-1443 | United States | Details | |
| Cleveland Clinic Main Campus /ID# 160756 | Cleveland | Ohio | 44195 | United States | Details | |
| University of Texas MD Anderson Cancer Center /ID# 160701 | Houston | Texas | 77030 | United States | Details | |
| Swedish-Center for Blood Disor /ID# 166487 | Seattle | Washington | 98104 | United States | Details |